青光眼风险、诊断和管理的新趋势。
New trends in glaucoma risk, diagnosis & management.
机构信息
Glaucoma & Retinal Neuro-degeneration Research Group, UCL Institute of Ophthalmology, London, United Kingdom.
出版信息
Indian J Med Res. 2013 Apr;137(4):659-68.
Abstract
Recent advances have seen a surge of new ideas and technologies to aid in the detection, treatment and further understanding of glaucoma. These technologies and advances are discussed to provide information on risk-factors, diagnosis and treatment. Glaucoma has never before seen such an advance in research and therapies coming forward in to the clinical workplace. It is an exciting time for physicians and researchers alike and over the next decade will certainly see advances in early detection, efficacious treatments and neuroprotection.
摘要
近年来，出现了许多新的理念和技术，以帮助检测、治疗和进一步了解青光眼。本文将讨论这些技术和进展，为读者提供有关风险因素、诊断和治疗的信息。青光眼在研究和治疗方面从未有过如此大的进展，这些新进展已经进入临床实践。这对医生和研究人员来说都是一个令人兴奋的时刻，在未来十年，肯定会在早期检测、有效治疗和神经保护方面取得进展。
相似文献
1
New trends in glaucoma risk, diagnosis & management.青光眼风险、诊断和管理的新趋势。
Indian J Med Res. 2013 Apr;137(4):659-68.
2
Glaucoma: Hot Topics in Pharmacology.青光眼：药理学热点话题
Curr Pharm Des. 2017;23(4):596-607. doi: 10.2174/1381612822666161129151308.
3
[Neuroprotection in glaucoma. What is the current status?].[青光眼的神经保护。现状如何？]
Ophthalmologe. 2001 Jun;98(6):564-7. doi: 10.1007/s003470170120.
4
Neuroprotection: a new treatment modality for glaucoma?神经保护：青光眼的一种新治疗方式？
Curr Opin Ophthalmol. 2000 Apr;11(2):107-11. doi: 10.1097/00055735-200004000-00007.
5
Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned.美金刚最近的临床研究结果并不意味着青光眼神经保护的理念被摒弃。
Acta Ophthalmol. 2009 Jun;87(4):450-4. doi: 10.1111/j.1755-3768.2008.01459.x. Epub 2009 Jan 9.
6
Assessment of neuroprotection in the retina with DARC.用趋化因子Duffy抗原/趋化因子受体（DARC）评估视网膜中的神经保护作用。
Prog Brain Res. 2008;173:437-50. doi: 10.1016/S0079-6123(08)01130-8.
7
Neuroprotective Strategies in Glaucoma.青光眼的神经保护策略
Curr Pharm Des. 2016;22(14):2178-92. doi: 10.2174/1381612822666160128144747.
8
A decade of proteomics studies of glaucomatous neurodegeneration.青光眼神经退行性变的十年蛋白质组学研究。
Proteomics Clin Appl. 2014 Apr;8(3-4):154-67. doi: 10.1002/prca.201300115. Epub 2014 Feb 16.
9
Neuroprotection and other novel therapies for glaucoma.青光眼的神经保护及其他新型疗法。
Curr Opin Pharmacol. 2013 Feb;13(1):1-4. doi: 10.1016/j.coph.2012.10.009. Epub 2012 Nov 7.
10
Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper.青光眼神经保护治疗的现状与展望：欧洲青光眼学会白皮书。
Cell Tissue Res. 2013 Aug;353(2):347-54. doi: 10.1007/s00441-013-1637-3. Epub 2013 May 28.
引用本文的文献
1
Advancing glaucoma detection with convolutional neural networks: a paradigm shift in ophthalmology.利用卷积神经网络推进青光眼检测：眼科学的范式转变。
Rom J Ophthalmol. 2023 Jul-Sep;67(3):222-237. doi: 10.22336/rjo.2023.39.
2
Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population-based cohort studies.肠易激综合征与青光眼风险：两项独立基于人群的队列研究分析。
United European Gastroenterol J. 2021 Nov;9(9):1057-1065. doi: 10.1002/ueg2.12136. Epub 2021 Aug 25.
3
The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer.玻璃体内注射地塞米松植入后眼压暂时升高对视网膜神经纤维层的影响。
Clin Ophthalmol. 2019 Jun 27;13:1079-1086. doi: 10.2147/OPTH.S201395. eCollection 2019.
4
Prevalence and risk factors of eye diseases in adult patients with obstructive sleep apnoea: results from the SLE.E.P.Y cohort study.阻塞性睡眠呼吸暂停成年患者眼部疾病的患病率及危险因素：SLE.E.P.Y队列研究结果
BMJ Open. 2017 Oct 22;7(10):e016142. doi: 10.1136/bmjopen-2017-016142.
5
Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.青光眼：生物小梁和神经视网膜病理学以及治疗创新与预防性诊断的前景
Front Neurosci. 2017 Sep 5;11:494. doi: 10.3389/fnins.2017.00494. eCollection 2017.
6
Many Faces of Renin-angiotensin System - Focus on Eye.肾素-血管紧张素系统的多面性——聚焦于眼部
Open Ophthalmol J. 2017 Jun 19;11:122-142. doi: 10.2174/1874364101711010122. eCollection 2017.
7
Effects of water drinking test on ocular blood flow waveform parameters: A laser speckle flowgraphy study.饮水试验对眼血流波形参数的影响：一项激光散斑血流图研究。
PLoS One. 2017 Jul 24;12(7):e0181512. doi: 10.1371/journal.pone.0181512. eCollection 2017.
8
Scientometric analysis and mapping of 20 years of glaucoma research.20年青光眼研究的科学计量分析与图谱绘制
Int J Ophthalmol. 2016 Sep 18;9(9):1329-35. doi: 10.18240/ijo.2016.09.17. eCollection 2016.
9
Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study.美金刚对青光眼大鼠视网膜的神经保护作用：一项电子显微镜研究
J Ophthalmic Vis Res. 2016 Apr-Jun;11(2):174-82. doi: 10.4103/2008-322X.183934.
10
Pharmacotherapy of glaucoma.青光眼的药物治疗
J Ocul Pharmacol Ther. 2015 Mar;31(2):63-77. doi: 10.1089/jop.2014.0067. Epub 2015 Jan 14.
本文引用的文献
1
24-hour intraocular pressure and ocular perfusion pressure in glaucoma.青光眼的 24 小时眼压和眼灌注压。
Surv Ophthalmol. 2013 Jan-Feb;58(1):26-41. doi: 10.1016/j.survophthal.2012.05.003.
2
Relationship between intraocular pressure and rate of visual field progression in treated glaucoma.治疗性青光眼的眼内压与视野进展率之间的关系。
J Glaucoma. 2013 Dec;22(9):719-24. doi: 10.1097/IJG.0b013e318259b0c2.
3
Continuous 24-hour intraocular pressure monitoring for glaucoma--time for a paradigm change.青光眼的 24 小时连续眼压监测——是时候改变范式了。
Swiss Med Wkly. 2012 Mar 28;142:w13545. doi: 10.4414/smw.2012.13545. eCollection 2012.
4
Ab interno trabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma.经内小梁切开术：剥脱综合征与原发性开角型青光眼的结果。
J Cataract Refract Surg. 2012 Feb;38(2):315-23. doi: 10.1016/j.jcrs.2011.08.043.
5
Cerebrospinal fluid exchange in the optic nerve in normal-tension glaucoma.正常眼压性青光眼视神经中的脑脊液交换。
Br J Ophthalmol. 2012 Apr;96(4):544-8. doi: 10.1136/bjophthalmol-2011-300663. Epub 2011 Nov 24.
6
A comparison of the Ex-PRESS™ mini glaucoma shunt with standard trabeculectomy in the surgical treatment of glaucoma.Ex-PRESS™微型青光眼分流器与标准小梁切除术在青光眼手术治疗中的比较。
Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec;42(6):453-9. doi: 10.3928/15428877-20111017-03.
7
Clinical evidence for neuroprotection in glaucoma.青光眼神经保护的临床证据。
Am J Ophthalmol. 2011 Nov;152(5):715-6. doi: 10.1016/j.ajo.2011.06.015.
8
Continuous IOP fluctuation recording in normal tension glaucoma patients.正常眼压性青光眼患者的连续眼压波动记录。
Curr Eye Res. 2011 Dec;36(12):1129-38. doi: 10.3109/02713683.2011.608240. Epub 2011 Oct 6.
9
Miniaturized high-intensity focused ultrasound device in patients with glaucoma: a clinical pilot study.青光眼患者的微型高强度聚焦超声设备：一项临床初步研究。
Invest Ophthalmol Vis Sci. 2011 Nov 11;52(12):8747-53. doi: 10.1167/iovs.11-8137.
10
Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.可生物降解胶原基质植入物与丝裂霉素 C 作为小梁切除术辅助剂的比较：一项 24 个月的随机临床试验。
Eye (Lond). 2011 Dec;25(12):1598-606. doi: 10.1038/eye.2011.219. Epub 2011 Sep 16.
Zotero 插件